Treatment of rat models of allergic rhinitis after particulate matter (PM2.5) exposure with RosA (20 mg/kg, i.p.)for 7 days remarkably reduced the levels of IL‐4 and IL‐13, while enhancing IFN‐γ levels in nasal lavage fluid. Here, IL13 is linked to allergic rhinitis.